vs
Side-by-side financial comparison of Bio-Techne (TECH) and TRUPANION, INC. (TRUP). Click either name above to swap in a different company.
TRUPANION, INC. is the larger business by last-quarter revenue ($376.9M vs $295.9M, roughly 1.3× Bio-Techne). On growth, TRUPANION, INC. posted the faster year-over-year revenue change (11.7% vs -6.4%). Over the past eight quarters, TRUPANION, INC.'s revenue compounded faster (11.0% CAGR vs 4.2%).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
TRUPANION, INC.TRUPEarnings & Financial Report
Trupanion, Inc. is a pet insurance provider headquartered in Seattle, Washington. Established in 1998, Trupanion operates across the United States, Canada, Australia, and Puerto Rico. The company offers coverage for pets and is self-underwritten by the American Pet Insurance Company (APIC).
TECH vs TRUP — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $376.9M |
| Net Profit | $38.0M | — |
| Gross Margin | 64.6% | 17.3% |
| Operating Margin | 18.4% | 1.9% |
| Net Margin | 12.8% | — |
| Revenue YoY | -6.4% | 11.7% |
| Net Profit YoY | 68.3% | — |
| EPS (diluted) | $0.24 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.9M | $376.9M | ||
| Q3 25 | — | $366.9M | ||
| Q2 25 | $317.0M | $353.6M | ||
| Q1 25 | $316.2M | $342.0M | ||
| Q4 24 | $297.0M | $337.3M | ||
| Q3 24 | $289.5M | $327.5M | ||
| Q2 24 | $306.1M | $314.8M | ||
| Q1 24 | $303.4M | $306.1M |
| Q4 25 | $38.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-17.7M | — | ||
| Q1 25 | $22.6M | — | ||
| Q4 24 | $34.9M | — | ||
| Q3 24 | $33.6M | — | ||
| Q2 24 | $40.6M | — | ||
| Q1 24 | $49.1M | — |
| Q4 25 | 64.6% | 17.3% | ||
| Q3 25 | — | 16.4% | ||
| Q2 25 | 62.7% | 15.5% | ||
| Q1 25 | 67.9% | 14.9% | ||
| Q4 24 | 65.3% | 15.7% | ||
| Q3 24 | 63.2% | 15.1% | ||
| Q2 24 | 66.4% | 12.8% | ||
| Q1 24 | 67.4% | 11.8% |
| Q4 25 | 18.4% | 1.9% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | -7.5% | 0.7% | ||
| Q1 25 | 12.2% | -0.4% | ||
| Q4 24 | 16.0% | 0.1% | ||
| Q3 24 | 13.8% | 0.5% | ||
| Q2 24 | 15.0% | -1.7% | ||
| Q1 24 | 22.1% | -2.0% |
| Q4 25 | 12.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -5.6% | — | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 13.3% | — | ||
| Q1 24 | 16.2% | — |
| Q4 25 | $0.24 | $0.13 | ||
| Q3 25 | — | $0.13 | ||
| Q2 25 | $-0.11 | $0.22 | ||
| Q1 25 | $0.14 | $-0.03 | ||
| Q4 24 | $0.22 | $0.04 | ||
| Q3 24 | $0.21 | $0.03 | ||
| Q2 24 | $0.26 | $-0.14 | ||
| Q1 24 | $0.31 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.9M | $370.7M |
| Total DebtLower is stronger | $260.0M | $101.8M |
| Stockholders' EquityBook value | $2.0B | $383.9M |
| Total Assets | $2.5B | $915.0M |
| Debt / EquityLower = less leverage | 0.13× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.9M | $370.7M | ||
| Q3 25 | — | $348.5M | ||
| Q2 25 | $162.2M | $319.6M | ||
| Q1 25 | $140.7M | $321.8M | ||
| Q4 24 | $177.5M | $307.4M | ||
| Q3 24 | $187.5M | $293.1M | ||
| Q2 24 | $152.9M | $277.2M | ||
| Q1 24 | $145.3M | $275.2M |
| Q4 25 | $260.0M | $101.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | $346.0M | — | ||
| Q1 25 | $330.0M | — | ||
| Q4 24 | $300.0M | $127.5M | ||
| Q3 24 | $300.0M | — | ||
| Q2 24 | $319.0M | — | ||
| Q1 24 | $389.0M | — |
| Q4 25 | $2.0B | $383.9M | ||
| Q3 25 | — | $368.6M | ||
| Q2 25 | $1.9B | $355.5M | ||
| Q1 25 | $2.0B | $333.7M | ||
| Q4 24 | $2.1B | $323.3M | ||
| Q3 24 | $2.1B | $320.2M | ||
| Q2 24 | $2.1B | $305.8M | ||
| Q1 24 | $2.0B | $303.4M |
| Q4 25 | $2.5B | $915.0M | ||
| Q3 25 | — | $880.2M | ||
| Q2 25 | $2.6B | $847.8M | ||
| Q1 25 | $2.6B | $837.2M | ||
| Q4 24 | $2.7B | $806.9M | ||
| Q3 24 | $2.7B | $816.1M | ||
| Q2 24 | $2.7B | $795.9M | ||
| Q1 24 | $2.7B | $789.5M |
| Q4 25 | 0.13× | 0.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.14× | 0.39× | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $29.3M |
| Free Cash FlowOCF − Capex | — | $25.3M |
| FCF MarginFCF / Revenue | — | 6.7% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $75.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.3M | ||
| Q3 25 | — | $29.2M | ||
| Q2 25 | $98.2M | $15.0M | ||
| Q1 25 | $41.1M | $16.0M | ||
| Q4 24 | $84.3M | $23.7M | ||
| Q3 24 | $63.9M | $15.3M | ||
| Q2 24 | $75.5M | $6.9M | ||
| Q1 24 | $81.0M | $2.4M |
| Q4 25 | — | $25.3M | ||
| Q3 25 | — | $23.9M | ||
| Q2 25 | $93.3M | $12.0M | ||
| Q1 25 | $31.0M | $14.0M | ||
| Q4 24 | $77.5M | $21.8M | ||
| Q3 24 | $54.7M | $13.4M | ||
| Q2 24 | $57.5M | $4.0M | ||
| Q1 24 | $64.5M | $-631.0K |
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 6.5% | ||
| Q2 25 | 29.4% | 3.4% | ||
| Q1 25 | 9.8% | 4.1% | ||
| Q4 24 | 26.1% | 6.5% | ||
| Q3 24 | 18.9% | 4.1% | ||
| Q2 24 | 18.8% | 1.3% | ||
| Q1 24 | 21.3% | -0.2% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | 1.5% | 0.8% | ||
| Q1 25 | 3.2% | 0.6% | ||
| Q4 24 | 2.3% | 0.6% | ||
| Q3 24 | 3.2% | 0.6% | ||
| Q2 24 | 5.9% | 0.9% | ||
| Q1 24 | 5.4% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 2.42× | — | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
TRUP
| Subscriptionbusiness | $261.4M | 69% |
| Other | $115.4M | 31% |
